Sodium–glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction

Wood, N., Straw, S., Cheng, C.W. orcid.org/0000-0002-2873-0828 et al. (9 more authors) (2024) Sodium–glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 26 (4). pp. 925-935. ISSN 1388-9842

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Authors. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: SGLT2 inhibitors; Muscle; Metabolism; Atrophy; HFrEF
Dates:
  • Published: April 2024
  • Published (online): 11 March 2024
  • Accepted: 23 February 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Clinical & Population Science Dept (Leeds)
The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Biomedical Sciences (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 26 Apr 2024 09:43
Last Modified: 15 Oct 2024 14:35
Status: Published
Publisher: Wiley
Identification Number: 10.1002/ejhf.3192
Related URLs:
Open Archives Initiative ID (OAI ID):

Commentary/Response Threads

Export

Statistics